<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="rearrangement of primary and anamnestic CD8+ T cell responses to" exact="influenza" post="A viral epitopes upon exposure to bacterial superantigens: Implications"/>
 <result pre="bacteria may precede or follow infection with or vaccination against" exact="influenza" post="A viruses (IAVs). However, how SAgs alter the breadth"/>
 <result pre="CD8+ T cell (TCD8) responses to respiratory viral pathogens, including" exact="influenza" post="A viruses (IAVs), is far from clear. Also importantly,"/>
 <result pre="a significant challenge in myriad life-threatening conditions and illnesses, including" exact="toxic shock syndrome" post="[1,2], sepsis [3,4], and influenza A virus (IAV) epidemics"/>
 <result pre="and illnesses, including toxic shock syndrome [1,2], sepsis [3,4], and" exact="influenza" post="A virus (IAV) epidemics and pandemics [5–9]. Some of"/>
 <result pre="reassortant IAV strains, a live attenuated nasal flu vaccine, and" exact="vaccinia virus" post="(VacV). The implications of our findings for sequential infections,"/>
 <result pre="Reserve strain of VacV was propagated in the thymidine kinase-deficient" exact="osteosarcoma" post="cell line 143B. WT and mutant Bacteria The methicillin-resistant"/>
 <result pre="epitopes (Table 1). NP118 is an immunodominant peptide epitope of" exact="lymphocytic choriomeningitis" post="virus (LCMV) [48] (Table 1) to which our animals"/>
 <result pre="E3L140-148 E3L140 VGPSNSPTF H2-Dd LCMV NP118-126 NP118 RPQASGVYM H2-Ld IAV:" exact="influenza" post="A virus; MHC: major histocompatibility complex; LCMV: lymphocytic choriomeningitis"/>
 <result pre="H2-Ld IAV: influenza A virus; MHC: major histocompatibility complex; LCMV:" exact="lymphocytic choriomeningitis" post="virus; VacV: vaccinia virus In vivo killing assay Carboxyfluorescein"/>
 <result pre="virus; MHC: major histocompatibility complex; LCMV: lymphocytic choriomeningitis virus; VacV:" exact="vaccinia virus" post="In vivo killing assay Carboxyfluorescein diacetate succinimidyl ester (CFSE)-based"/>
 <result pre="which may potentially affect their significance in the context of" exact="influenza" post="following exposure to the toxins or bacterial pathogens that"/>
 <result pre="in vaccine formulations to protect against other infectious diseases, including" exact="influenza" post="[82,83,84]; iv) several VacV-derived epitopes have been identified in"/>
 <result pre="2011;1–3. 2SionM, HatzitoliosA, ToulisE, MikoudiK, ZiakasGet al.Toxic shock syndrome complicating" exact="influenza" post="A infection: a two-case report with one case of"/>
 <result pre="Care Medicine. 2001;27(2):44310.1007/s001340000803 .11396292 3FlorescuD, KalilA. The complex link between" exact="influenza" post="and severe sepsis.Virulence. 2013;5(1):137–142. 10.4161/viru.27103 .24253109 4Martin-LoechesI, LemialeV, GeogheganP,"/>
 <result pre="Biology. 2017;15(6):e200193010.1371/journal.pbio.2001930 .28632753 13GuoX, ThomasP. New fronts emerge in the" exact="influenza" post="cytokine storm. Seminars in Immunopathology. 2017;39(5):541–550. .28555383 14YewdellJ, HaeryfarS."/>
 <result pre="of Immunology. 2005;23:651–682. 10.1146/annurev.immunol.23.021704.115702 .15771583 15BrownL, KelsoA. Prospects for an" exact="influenza" post="vaccine that induces cross-protective cytotoxic T lymphocytes. Immunology and"/>
 <result pre="Antibody Selection. Cell Host &amp;amp;Microbe. 2013;13(3):314–323. 10.1016/j.chom.2013.02.008 .23498956 35KilbourneED. Future" exact="influenza" post="vaccines and the use of genetic recombinants. Bulletin of"/>
 <result pre="36BenninkJ, YewdellJ, GerhardW. A viral polymerase involved in recognition of" exact="influenza" post="virus-infected cells by a cytotoxic T-cell clone. Nature. 1982;296(5852):75–76."/>
 <result pre="staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent" exact="toxic shock syndrome." post="Nature Medicine. 2009;15(6):641–648. 10.1038/nm.1965 .19465927 40KapplerJ, HermanA, ClementsJ, MarrackP."/>
 <result pre="2009;157(1):60–70. 10.1111/j.1365-2249.2009.03963.x .19659771 44HosakaY, SasaoF, OharaR. Cell-mediated lysis of heat-inactivated" exact="influenza" post="virus-coated murine targets. Vaccine. 1985;3:245–251. 10.1016/0264-410x(85)90116-1 .3877382 45HuffordM, RichardsonG,"/>
 <result pre="TanB, KedzierskaKet al.Systematic identification of immunodominant CD8+ T-cell responses to" exact="influenza" post="A virus in HLA-A2 individuals. Proceedings of the National"/>
 <result pre="2011;108(22):9178–9183. 10.1073/pnas.1105624108 .21562214 76GrantE, WuC, ChanK, EckleS, BharadwajMet al.Nucleoprotein of" exact="influenza" post="A virus is a major target of immunodominant CD8+"/>
 <result pre="LohL, ClemensE, SantSet al.Broad CD8+ T cell cross-recognition of distinct" exact="influenza" post="A strains in humans. Nature Communications. 2018;9(1):542710.1038/s41467-018-07815-5 .30575715 78VoetenJ,"/>
 <result pre="Respiratory Diseases.Viruses. 2014;6(7):2735–2761. 10.3390/v6072735 .25036462 83de VriesR, RimmelzwaanG. Viral vector-based" exact="influenza" post="vaccines.Human Vaccines &amp;amp; Immunotherapeutics. 2016;12(11):2881–2901. 10.1080/21645515.2016.1210729 .27455345 84de VriesR,"/>
 <result pre="UsherwoodE. CD4+ T-cell dependence of primary CD8+ T-cell response against" exact="vaccinia virus" post="depends upon route of infection and viral dose. Cellular"/>
</results>
